Literature DB >> 12380371

Juvenile dermatomyositis: immunogenetics, pathophysiology, and disease expression.

Lauren M Pachman1.   

Abstract

Data are rapidly accumulating documenting disease susceptibility may be linked to genetic markers (DQA1*0501 or related alleles) which are associated with upregulation of IFN-alpha/beta inducible genes elicited in response to an antigen which may be viral. Continued immune-mediated inflammation, resulting in partial lipodystrophy and pathological calcifications, may be fanned by the increased production of TNF alpha usually associated with the TNF alpha-308A allele.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12380371     DOI: 10.1016/s0889-857x(02)00013-3

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  10 in total

Review 1.  Dermatomyositis.

Authors:  M S Krathen; D Fiorentino; V P Werth
Journal:  Curr Dir Autoimmun       Date:  2008

2.  Serum protein biomarkers for juvenile dermatomyositis: a pilot study.

Authors:  Shefa M Tawalbeh; Wilfredo Marin; Gabrielle A Morgan; Utkarsh J Dang; Yetrib Hathout; Lauren M Pachman
Journal:  BMC Rheumatol       Date:  2020-10-01

Review 3.  Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment.

Authors:  Adam M Huber
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

4.  Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling.

Authors:  Ally-Khan Somani; Alan R Swick; Kevin D Cooper; Thomas S McCormick
Journal:  Arch Dermatol       Date:  2008-10

Review 5.  Calcinosis Biomarkers in Adult and Juvenile Dermatomyositis.

Authors:  Melody P Chung; Carrie Richardson; David Kirakossian; Amir B Orandi; Lesley A Saketkoo; Lisa G Rider; Adam Schiffenbauer; Carlos A von Mühlen; Lorinda Chung
Journal:  Autoimmun Rev       Date:  2020-03-28       Impact factor: 9.754

6.  Is juvenile dermatomyositis a different disease in children up to three years of age at onset than in children above three years at onset? A retrospective review of 23 years of a single center's experience.

Authors:  Anjali Patwardhan; Robert Rennebohm; Igor Dvorchik; Charles H Spencer
Journal:  Pediatr Rheumatol Online J       Date:  2012-09-20       Impact factor: 3.054

7.  Juvenile dermatomyositis: the role of cytokine gene polymorphisms in conferring risk and protection.

Authors:  Emma Jane MacDermott; Thomas J A Lehman
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.686

8.  Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study.

Authors:  Gail Faller; Bhadrish J Mistry; Mohammed Tikly
Journal:  Pediatr Rheumatol Online J       Date:  2014-01-07       Impact factor: 3.054

9.  Unilateral heliotrope rash in juvenile dermatomyositis: an unusual presentation of an underlying serious disease.

Authors:  Ghada Al-Janobi; Hisham Alkhalidi; Mohammed A Omair
Journal:  Case Rep Rheumatol       Date:  2014-12-22

10.  MRI guided wire localization muscle biopsy in a child with juvenile dermatomyositis.

Authors:  Victoria C Tuen; Shannon N Zingula; Christopher Moir; Ann M Reed; Jane M Matsumoto; David A Woodrum
Journal:  Pediatr Rheumatol Online J       Date:  2013-04-08       Impact factor: 3.054

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.